Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Results Reported From Three NCI-Sponsored Clinical Trials
02-Jul-2007 -
Cytokinetics, Incorporated announced results from the analyses of three Phase II clinical trials of ispinesib administered as monotherapy, one in patients with hepatocellular cancer, one in patients with melanoma, and one in patients with hormone-refractory prostate cancer. Ispinesib is a small ...
cell division
chemotherapy
clinical trials
+6